| Year |
Citation |
Score |
| 2021 |
Quintanilha JCF, Wang J, Sibley AB, Xu W, Espin-Garcia O, Jiang C, Etheridge AS, Ratain MJ, Lenz HJ, Bertagnolli M, Kindler HL, Dickler MN, Venook A, Liu G, Owzar K, et al. Genome-wide association studies of survival in 1,520 cancer patients treated with bevacizumab-containing regimens. International Journal of Cancer. PMID 34528705 DOI: 10.1002/ijc.33810 |
0.316 |
|
| 2020 |
Innocenti F, Sibley AB, Patil SA, Etheridge AS, Jiang C, Ou FS, Howell S, Plummer SJ, Casey G, Bertagnolli MM, McLeod HL, Auman JT, Blanke CD, Furukawa Y, Venook AP, ... ... Owzar K, et al. Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32958699 DOI: 10.1158/1078-0432.Ccr-20-2021 |
0.411 |
|
| 2020 |
Liu Y, Lyu J, Bell Burdett K, Sibley AB, Hatch AJ, Starr MD, Brady JC, Hammond K, Marmorino F, Rossini D, Goldberg RM, Falcone A, Cremolini C, Owzar K, Ivanova A, et al. Prognostic and Predictive Biomarkers in Metastatic Colorectal Cancer Patients Receiving Regorafenib. Molecular Cancer Therapeutics. PMID 32747417 DOI: 10.1158/1535-7163.Mct-20-0249 |
0.37 |
|
| 2020 |
Chua KC, Xiong C, Ho C, Mushiroda T, Jiang C, Mulkey F, Lai D, Schneider BP, Rashkin SR, Witte JS, Friedman PN, Ratain MJ, McLeod HL, Rugo HS, Shulman LN, ... ... Owzar K, et al. Genome-Wide Meta-Analysis Validates a Roless for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy. Clinical Pharmacology and Therapeutics. PMID 32562552 DOI: 10.1002/Cpt.1958 |
0.372 |
|
| 2020 |
Holstein SA, Suman VJ, Owzar K, Santo K, Benson DM, Shea TC, Martin T, Silverman M, Isola L, Vij R, Cheson BD, Linker C, Anderson KC, Richardson PG, McCarthy PL. Long-term follow-up of CALGB (Alliance) 100001: Autologous followed by non-myeloablative allogeneic transplant for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32325171 DOI: 10.1016/J.Bbmt.2020.03.028 |
0.366 |
|
| 2020 |
Wu Y, Wang X, Lin J, Jia B, Owzar K. Predictive accuracy of markers or risk scores for interval censored survival data. Statistics in Medicine. PMID 32293745 DOI: 10.1002/Sim.8547 |
0.326 |
|
| 2020 |
Alvarez Secord A, Bell Burdett K, Owzar K, Tritchler D, Sibley AB, Liu Y, Starr MD, Brady JC, Lankes HA, Hurwitz HI, Mannel RS, Tewari KS, O'Malley DM, Gray H, Bakkum-Gamez JN, et al. Predictive blood-based biomarkers in epithelial ovarian cancer patients treated with carboplatin and paclitaxel with or without bevacizumab: Results from GOG-0218. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31919136 DOI: 10.1158/1078-0432.Ccr-19-0226 |
0.379 |
|
| 2020 |
Siamakpour-Reihani S, Cobb LP, Jiang C, Zhang D, Previs RA, Owzar K, Nixon AB, Alvarez Secord A. Differential expression of immune related genes in high-grade ovarian serous carcinoma. Gynecologic Oncology. PMID 31918995 DOI: 10.1016/J.Ygyno.2019.12.019 |
0.353 |
|
| 2020 |
Deveaux AE, Zhang D, Abo MA, Barrett NJ, Kittles RA, Owzar K, McCall SJ, Crawford J, Patierno SR, Clarke JM, Freedman JA. Abstract B071: Genomic differences between non-small cell lung cancer (NSCLC) in African American and white patients Cancer Epidemiology, Biomarkers & Prevention. 29. DOI: 10.1158/1538-7755.Disp18-B071 |
0.383 |
|
| 2020 |
Force J, Qin X, Zhang D, Marcom PK, Marks J, Taylor ML, Anders C, Owzar K, Xie J. Abstract P1-06-02: Characterization of gene- and sample-level APOBEC mutagenesis enrichment with respect to intrinsic subtypes, tumor mutational burden, and immune composition in breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P1-06-02 |
0.316 |
|
| 2019 |
Vij R, Le-Rademacher J, Laumann K, Hars V, Owzar K, Shore T, Vasu S, Cashen A, Isola L, Shea T, DeMagalhaes-Silverman M, Hurd D, Meehan K, Beardell F, Devine S. A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acute myeloid leukemia: CALGB 100801 (Alliance). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31212080 DOI: 10.1016/J.Bbmt.2019.06.007 |
0.354 |
|
| 2019 |
Innocenti F, Jiang C, Sibley AB, Denning S, Etheridge AS, Watson D, Niedzwiecki D, Hatch AJ, Hurwitz HI, Nixon AB, Furukawa Y, Kubo M, Crona DJ, Kindler HL, McLeod HL, ... ... Owzar K, et al. An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients CALGB 80303 (Alliance). Pharmacogenetics and Genomics. PMID 30889042 DOI: 10.1097/Fpc.0000000000000375 |
0.357 |
|
| 2019 |
Liu Y, Burdett K, Starr MD, Brady JC, Hatch AJ, Ivanova A, Moore DT, Hammond K, Lee MS, O'Neil B, Innocenti F, Owzar K, Sanoff HK, Nixon AB. Blood-based biomarkers in metastatic colorectal cancer patients treated with FOLFIRI plus regorafenib or placebo: Results from LCCC1029. Journal of Clinical Oncology. 37: 587-587. DOI: 10.1200/Jco.2019.37.4_Suppl.587 |
0.371 |
|
| 2019 |
Poe JC, Zhang D, Xie J, DiCioccio RA, Qin X, Fang J, Ho VT, Rose JJ, Pavletic SZ, Hakim FT, Jia W, Suthers AN, Horwitz ME, Rizzieri DA, McManigle WC, ... ... Owzar K, et al. Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd Blood. 134: 874-874. DOI: 10.1182/Blood-2019-130928 |
0.301 |
|
| 2018 |
Innocenti F, Jiang C, Sibley AB, Denning S, Etheridge AS, Watson D, Niedzwiecki D, Hatch AJ, Hurwitz H, Nixon A, Furukawa Y, Kubo M, Crona DJ, Kindler H, McLeod HL, ... ... Owzar K, et al. A genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: viii661-viii662. PMID 32137805 DOI: 10.1093/Annonc/Mdy303.038 |
0.351 |
|
| 2018 |
Brander DM, Friedman DR, Volkheimer AD, Christensen DJ, Rassenti LZ, Kipps TJ, Guadalupe E, Chen Y, Zhang D, Wang X, Davis C, Owzar K, Weinberg JB. SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia. British Journal of Haematology. PMID 30443898 DOI: 10.1111/Bjh.15677 |
0.327 |
|
| 2018 |
Innocenti F, Jiang C, Sibley AB, Etheridge AS, Hatch AJ, Denning S, Niedzwiecki D, Shterev ID, Lin J, Furukawa Y, Kubo M, Kindler HL, Auman JT, Venook AP, Hurwitz HI, ... ... Owzar K, et al. Genetic variation determines VEGF-A plasma levels in cancer patients. Scientific Reports. 8: 16332. PMID 30397360 DOI: 10.1038/S41598-018-34506-4 |
0.352 |
|
| 2018 |
Rashkin SR, Chua KC, Ho C, Mulkey F, Jiang C, Mushiroda T, Kubo M, Friedman PN, Rugo HS, McLeod HL, Ratain MJ, Castillos F, Naughton M, Overmoyer B, Toppmeyer D, ... ... Owzar K, et al. A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance). Clinical Pharmacology and Therapeutics. PMID 30260474 DOI: 10.1002/Cpt.1241 |
0.37 |
|
| 2018 |
Innocenti F, Owzar K, Jiang C, Etheridge AS, Gordân R, Sibley AB, Mulkey F, Niedzwiecki D, Glubb D, Neel N, Talamonti MS, Bentrem DJ, Seiser E, Yeh JJ, Van Loon K, et al. The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. Plos One. 13: e0202272. PMID 30107003 DOI: 10.1371/Journal.Pone.0202272 |
0.386 |
|
| 2018 |
Li Z, Wang X, Wu Y, Owzar K. Sample size calculation for studies with grouped survival data. Statistics in Medicine. PMID 29888484 DOI: 10.1002/Sim.7847 |
0.308 |
|
| 2018 |
Li M, Mulkey F, Jiang C, O'Neill BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, ... ... Owzar K, et al. Identification of a Genomic Region Between and Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29871907 DOI: 10.1158/1078-0432.Ccr-17-1523 |
0.314 |
|
| 2018 |
Sucheston-Campbell LE, Clay-Gilmour AI, Barlow WE, Budd GT, Stram DO, Haiman CA, Sheng X, Yan L, Zirpoli G, Yao S, Jiang C, Owzar K, Hershman D, Albain KS, Hayes DF, et al. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci. Pharmacogenetics and Genomics. 28: 49-55. PMID 29278617 DOI: 10.1097/Fpc.0000000000000318 |
0.362 |
|
| 2018 |
Shepshelovich D, Townsend AR, Espin-Garcia O, Latifovic L, O'Callaghan CJ, Jonker DJ, Tu D, Chen E, Morgen E, Price TJ, Shapiro JD, Siu LL, Owzar K, Ratain MJ, Kubo M, et al. The Association of FCGR2A and FCGR3A polymorphisms with outcomes in cetuximab treated metastatic colorectal cancer patients: CCTG and AGITG CO.20 trial analysis. Journal of Clinical Oncology. 36: 633-633. DOI: 10.1200/Jco.2018.36.4_Suppl.633 |
0.331 |
|
| 2018 |
Deveaux A, Wang B, Lacroix B, Patierno B, Zhang D, Owzar K, Lee N, George D, Freedman J, Patierno S. Abstract B59: Race-related differential splicing of the insulin receptor: A novel target underlying prostate cancer disparities Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-B59 |
0.329 |
|
| 2017 |
Duan B, Hu J, Liu H, Wang Y, Li H, Liu S, Xie J, Owzar K, Abbruzzese J, Hurwitz H, Gao H, Wei Q. Genetic Variants in the Platelet-Derived Growth Factor Subunit B Gene Associated with Pancreatic Cancer Risk. International Journal of Cancer. PMID 29168174 DOI: 10.1002/Ijc.31171 |
0.37 |
|
| 2017 |
Feng Y, Wang Y, Liu H, Liu Z, Mills C, Owzar K, Xie J, Han Y, Qian DC, Rj RJH, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, et al. Novel Genetic Variants in the P38MAPK Pathway Gene ZAK and Susceptibility to Lung Cancer. Molecular Carcinogenesis. PMID 29071797 DOI: 10.1002/Mc.22748 |
0.348 |
|
| 2017 |
Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, van Besien K, Gentile TG, Isola L, ... ... Owzar K, et al. Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. The Lancet. Haematology. PMID 28826616 DOI: 10.1016/S2352-3026(17)30140-0 |
0.343 |
|
| 2017 |
Liu H, Liu Z, Wang Y, Stinchcombe TE, Owzar K, Han Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, Caporaso N, Landi MT, et al. Functional variants in DCAF4 associated with lung cancer risk in European populations. Carcinogenesis. PMID 28383684 DOI: 10.1093/Carcin/Bgx033 |
0.343 |
|
| 2017 |
Han P, Gao F, Liu H, Liu Z, Shi Q, Troy JD, Owzar K, Lee W, Zevallos JP, Sturgis EM, Wei Q. Reduced mRNA Expression of Nucleotide Excision Repair Genes in Lymphocytes and Risk of Squamous Cell Carcinoma of the Head and Neck. Carcinogenesis. PMID 28379545 DOI: 10.1093/Carcin/Bgx028 |
0.324 |
|
| 2017 |
Pan Y, Liu H, Wang Y, Kang X, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, et al. Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Scientific Reports. 7: 44634. PMID 28304396 DOI: 10.1038/Srep44634 |
0.351 |
|
| 2017 |
Heinrich M, Rankin C, Blanke CD, Demetri GD, Borden EC, Ryan CW, von Mehren M, Blackstein ME, Priebat DA, Tap WD, Maki RG, Corless CL, Fletcher JA, Owzar K, Crowley JJ, et al. Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. Jama Oncology. PMID 28196207 DOI: 10.1001/Jamaoncol.2016.6728 |
0.31 |
|
| 2017 |
Yin J, Liu H, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeboeller H, Rosenberger A, Houlston RS, Caporaso N, et al. Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus. Molecular Carcinogenesis. PMID 28150878 DOI: 10.1002/Mc.22622 |
0.365 |
|
| 2016 |
Yuan H, Liu H, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, McLaughlin J, Brhane Y, Brennan P, Bickeboeller H, Rosenberger A, Houlston RS, Caporaso N, et al. A Novel Genetic Variant in Long Non-coding RNA Gene NEXN-AS1 is Associated with Risk of Lung Cancer. Scientific Reports. 6: 34234. PMID 27713484 DOI: 10.1038/Srep34234 |
0.344 |
|
| 2016 |
Longo T, McGinley KF, Freedman JA, Etienne W, Wu Y, Sibley A, Owzar K, Gresham J, Moy C, Szabo S, Greshock J, Zhou H, Bai Y, Inman BA. Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer. European Urology. PMID 27520487 DOI: 10.1016/J.Eururo.2016.07.049 |
0.36 |
|
| 2016 |
Hatch AJ, Sibley AB, Starr MD, Brady JC, Jiang C, Jia J, Bowers DL, Pang H, Owzar K, Niedzwiecki D, Innocenti F, Venook AP, Hurwitz HI, Nixon AB. Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Cancer Medicine. PMID 27465221 DOI: 10.1002/Cam4.806 |
0.353 |
|
| 2016 |
Hertz DL, Owzar K, Lessans S, Wing C, Jiang C, Kelly WK, Patel JN, Halabi S, Furukawa Y, Wheeler HE, Sibley A, Lassiter C, Weisman LS, Watson D, Krens SD, et al. Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27143689 DOI: 10.1158/1078-0432.Ccr-15-2823 |
0.315 |
|
| 2016 |
Friedman DR, Sibley AB, Owzar K, Chaffee KG, Slager S, Kay NE, Hanson CA, Ding W, Shanafelt TD, Weinberg JB, Wilcox RA. Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: A multi-institutional study. American Journal of Hematology. PMID 27037726 DOI: 10.1002/Ajh.24376 |
0.354 |
|
| 2016 |
Kang X, Liu H, Onaitis MW, Liu Z, Owzar K, Han Y, Su L, Wei Y, Hung RJ, Brhane Y, McLaughlin J, Brennan P, Bickeböller H, Rosenberger A, Houlston RS, et al. Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14 463 cases and 44 188 controls. Carcinogenesis. PMID 26905588 DOI: 10.1093/Carcin/Bgw014 |
0.358 |
|
| 2016 |
Innocenti F, Owzar K, Jiang C, Sibley A, Mulkey F, Carey LA, Tripathy D, Schneider BP, Barry WT, Winer EP, Hudis CA, McLeod HL, Dickler MN. A genome-wide association study (GWAS) of progression-free survival (PFS) in metastatic breast cancer (MBC) patients treated with letrozole (L) with or without bevacizumab (B) in CALGB 40503. Journal of Clinical Oncology. 34: 538-538. DOI: 10.1200/Jco.2016.34.15_Suppl.538 |
0.366 |
|
| 2016 |
Nixon AB, Sibley A, Hatch AJ, Liu Y, Jiang C, Mulkey F, Starr MD, Brady JC, Niedzwiecki D, Innocenti F, Venook AP, Hochster HS, Lenz H, O'Neil BH, Owzar K, et al. Blood-based biomarkers in patients (pts) with metastatic colorectal cancer (mCRC) treated with FOLFOX or FOLFIRI plus bevacizumab (Bev), cetuximab (Cetux), or Bev plus Cetux: Results from CALGB 80405 (Alliance). Journal of Clinical Oncology. 34: 3597-3597. DOI: 10.1200/Jco.2016.34.15_Suppl.3597 |
0.371 |
|
| 2016 |
Innocenti F, Jiang C, Sibley A, Etheridge A, Furukawa Y, Kubo M, Kindler HL, Venook AP, Hurwitz HI, Nixon AB, Owzar K. Abstract 3388: Genetic prediction of VEGF-A plasma levels in cancer patients Cancer Research. 76: 3388-3388. DOI: 10.1158/1538-7445.Am2016-3388 |
0.387 |
|
| 2016 |
Patel JN, Jiang C, Owzar K, Hertz DL, Mulkey FA, Kelly WK, Halabi S, Furukawa Y, Lassiter C, Dorsey SG, Friedman PN, Small EJ, Carducci MA, Mahoney JF, Kelley MJ, et al. Abstract 2037: A discovery study to identify clinical and genetic risk factors for bevacizumab (BEV)-related gastrointestinal (GI) hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated on CALGB 90401 (Alliance) Cancer Research. 76: 2037-2037. DOI: 10.1158/1538-7445.Am2016-2037 |
0.385 |
|
| 2015 |
Devine SM, Owzar K, Blum W, Mulkey F, Stone RM, Hsu JW, Champlin RE, Chen YB, Vij R, Slack J, Soiffer RJ, Larson RA, Shea TC, Hars V, Sibley AB, et al. Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26527780 DOI: 10.1200/Jco.2015.62.7273 |
0.353 |
|
| 2015 |
Siamakpour-Reihani S, Owzar K, Jiang C, Turner T, Deng Y, Bean SM, Horton JK, Berchuck A, Marks JR, Dewhirst MW, Secord AA. Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma. Gynecologic Oncology. PMID 26260910 DOI: 10.1016/J.Ygyno.2015.08.001 |
0.338 |
|
| 2015 |
Dressler LG, Deal AM, Owzar K, Watson D, Donahue K, Friedman PN, Ratain MJ, McLeod HL. Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance). Journal of the National Cancer Institute. 107. PMID 26160883 DOI: 10.1093/Jnci/Djv188 |
0.338 |
|
| 2015 |
Glubb DM, Paré-Brunet L, Jantus-Lewintre E, Jiang C, Crona D, Etheridge AS, Mirza O, Zhang W, Seiser EL, Rzyman W, Jassem J, Auman T, Hirsch FR, Owzar K, Camps C, et al. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 1067-75. PMID 26134224 DOI: 10.1097/Jto.0000000000000549 |
0.372 |
|
| 2015 |
Siamakpour-Reihani S, Owzar K, Jiang C, Scarbrough PM, Craciunescu OI, Horton JK, Dressman HK, Blackwell KL, Dewhirst MW. Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 31: 386-95. PMID 25811737 DOI: 10.3109/02656736.2015.1016557 |
0.353 |
|
| 2015 |
Cushman SM, Jiang C, Hatch AJ, Shterev I, Sibley AB, Niedzwiecki D, Venook AP, Owzar K, Hurwitz HI, Nixon AB. Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1078-86. PMID 25520391 DOI: 10.1158/1078-0432.Ccr-14-2313 |
0.385 |
|
| 2015 |
Patel JN, Jiang C, Hertz DL, Mulkey FA, Owzar K, Halabi S, Ratain MJ, Friedman PN, Small EJ, Carducci MA, Mahoney JF, Kelley MJ, Morris MJ, Kelly WK, McLeod HL. Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance). Cancer. 121: 1025-31. PMID 25417775 DOI: 10.1002/Cncr.29169 |
0.344 |
|
| 2015 |
Holstein SA, Owzar K, Richardson PG, Jiang C, Hofmeister CC, Hassoun H, Hurd DD, Stadtmauer EA, Giralt S, Devine SM, Hars V, Postiglione JR, Weisdorf DJ, Vij R, Moreb JS, et al. Updated analysis of CALGB/ECOG/BMT CTN 100104: Lenalidomide (Len) vs. placebo (PBO) maintenance therapy after single autologous stem cell transplant (ASCT) for multiple myeloma (MM). Journal of Clinical Oncology. 33: 8523-8523. DOI: 10.1200/Jco.2015.33.15_Suppl.8523 |
0.33 |
|
| 2015 |
Innocenti F, Owzar K, Jiang C, Sibley A, Niedzwiecki D, Lenz H, Bertagnolli MM, Friedman PN, Furukawa Y, Kubo M, Ratain MJ, Blanke CD, Venook AP, McLeod HL. A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405. Journal of Clinical Oncology. 33: 3599-3599. DOI: 10.1200/Jco.2015.33.15_Suppl.3599 |
0.401 |
|
| 2015 |
Siamakpour-Reihani S, Chen W, Lee C, Zhou Y, Owzar K, Chi J, Horton JK. Abstract 3331: Gene expression profiling after radiation in human breast cancer specimens and breast cancer cell lines Cancer Research. 75: 3331-3331. DOI: 10.1158/1538-7445.Am2015-3331 |
0.322 |
|
| 2015 |
Innocenti F, Owzar K, Chen J, Sibley A, Niedzwiecki D, Bertagnolli M, Friedman P, Furukawa Y, Kubo M, Ratain M, Blanke C, Heinz-Josef L, Venook A, McLeod H. 2007 A genome-wide association study (GWAS) of overall survival (OS) in 609 metastatic colorectal cancer (mCRC) patients treated with chemotherapy and biologics in CALGB 80405 European Journal of Cancer. 51. DOI: 10.1016/S0959-8049(16)30932-7 |
0.399 |
|
| 2014 |
Espin-Garcia O, Liu G, Owzar K, Kroetz D, Marsh S, Perrin T, Adusei C, Farrelly L, Embleton A, Swart AM, Parmar MK, Kaplan R, Kubo M, Ratain MJ, Matsuda K, et al. 180PGENOME-WIDE ASSOCIATION STUDY (GWAS) IDENTIFIES CANDIDATE NEUROTOXICITY MARKERS IN PLATINUM-TAXANE TREATED OVARIAN CANCER PATIENTS IN ICON7. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv62-iv63. PMID 28172135 DOI: 10.1093/Annonc/Mdu326.14 |
0.416 |
|
| 2014 |
Mackay H, Espin-Garcia O, Owzar K, Marsh S, Perrin T, Adusei C, Farrelly L, Embleton A, Swart AM, Parmar MK, Kaplan R, Kubo M, Ratain MJ, Matsuda K, Xu W, et al. 879PDNOVEL PHARMACOGENETIC GERMLINE CANDIDATES OF BEVACIZUMAB-RELATED SURVIVAL IN THE ICON7 TRIAL OF ADVANCED STAGE OVARIAN CANCER. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv306. PMID 28172041 DOI: 10.1093/Annonc/Mdu338.5 |
0.42 |
|
| 2014 |
Beumer JH, Owzar K, Lewis LD, Jiang C, Holleran JL, Christner SM, Blum W, Devine S, Kolitz JE, Linker C, Vij R, Alyea EP, Larson RA, Ratain MJ, Egorin MJ. Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). Cancer Chemotherapy and Pharmacology. 74: 927-38. PMID 25163570 DOI: 10.1007/S00280-014-2571-0 |
0.315 |
|
| 2014 |
Van Loon K, Owzar K, Jiang C, Kindler HL, Mulcahy MF, Niedzwiecki D, O'Reilly EM, Fuchs C, Innocenti F, Venook AP. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). Journal of the National Cancer Institute. 106. PMID 25099612 DOI: 10.1093/Jnci/Dju185 |
0.33 |
|
| 2014 |
Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, ... ... Owzar K, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nature Genetics. 46: 994-1000. PMID 25086665 DOI: 10.1038/Ng.3052 |
0.303 |
|
| 2014 |
Davidson BA, Rubatt JM, Corcoran DL, Teoh DK, Bernardini MQ, Grace LA, Soper WJ, Berchuck A, Siamakpour-Reihani S, Chen W, Owzar K, Murphy SK, Secord AA. Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines. Frontiers in Oncology. 4: 163. PMID 24999452 DOI: 10.3389/Fonc.2014.00163 |
0.324 |
|
| 2014 |
Corless CL, Ballman KV, Antonescu CR, Kolesnikova V, Maki RG, Pisters PW, Blackstein ME, Blanke CD, Demetri GD, Heinrich MC, von Mehren M, Patel S, McCarter MD, Owzar K, DeMatteo RP. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 1563-70. PMID 24638003 DOI: 10.1200/Jco.2013.51.2046 |
0.321 |
|
| 2014 |
Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, Li M, Winer EP, Hudis CA, Zembutsu H, Kubo M, Nakamura Y, McLeod HL, Ratain MJ, Shulman LN, et al. Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). The Pharmacogenomics Journal. 14: 336-42. PMID 24513692 DOI: 10.1038/Tpj.2014.2 |
0.332 |
|
| 2014 |
RamÃrez J, Kim TW, Liu W, Myers JL, Mirkov S, Owzar K, Watson D, Mulkey F, Gamazon ER, Stock W, Undevia S, Innocenti F, Ratain MJ. A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469. Pharmacogenetics and Genomics. 24: 129-32. PMID 24300566 DOI: 10.1097/Fpc.0000000000000023 |
0.34 |
|
| 2014 |
Patel JN, Jiang C, Hertz DL, Mulkey F, Friedman PN, Halabi S, Ratain MJ, Morris MJ, Small EJ, Owzar K, Kelly WK, McLeod HL. Bevacizumab (BEV) and risk of hemorrhage (HEM) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401 (ALLIANCE). Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E16061 |
0.355 |
|
| 2014 |
Hertz DL, Jiang C, Owzar K, Halabi S, Kelly WK, Mulkey F, Patel JN, Carducci MA, Kelley MJ, Stadler WM, Mohamed MK, Morris MJ, Nakamura Y, Zembutsu H, Ratain MJ, et al. A genome-wide association study (GWAS) of docetaxel-induced neutropenia in CALGB 90401/60404 (Alliance). Journal of Clinical Oncology. 32: 9612-9612. DOI: 10.1200/Jco.2014.32.15_Suppl.9612 |
0.324 |
|
| 2014 |
Demetri GD, Rankin CJ, Benjamin RS, Borden EC, Ryan CW, Priebat DA, Tap WD, Mehren Mv, Blackstein ME, Heinrich MC, Maki RG, Corless CL, Fletcher JA, Owzar K, Blanke CD. Long-term disease control of advanced gastrointestinal stromal tumors (GIST) with imatinib (IM): 10-year outcomes from SWOG phase III intergroup trial S0033. Journal of Clinical Oncology. 32: 10508-10508. DOI: 10.1200/Jco.2014.32.15_Suppl.10508 |
0.346 |
|
| 2014 |
Vij R, Hars V, Blum W, Shore TB, Rapoport AP, Shea TC, Hoke E, Stone RM, Friedman P, Owzar K, Devine SM. CALGB 100801 (Alliance): A Phase II Multi-Center NCI Cooperative Group Study of the Addition of Azacitidine (AZA) to Reduced-Intensity Conditioning (RIC) Allogeneic Transplantation for High Risk Myelodysplasia (MDS) and Older Patients with Acute Myeloid Leukemia (AML): Results of a “test dose” Strategy to Target Busulfan Exposure Blood. 124: 543-543. DOI: 10.1182/Blood.V124.21.543.543 |
0.358 |
|
| 2014 |
Patel JN, Jiang C, Hertz DL, Mulkey FA, Friedman PN, Halabi S, Ratain MJ, Morris MJ, Small EJ, Owzar K, Kelly WK, McLeod HL. Abstract 3841: Bevacizumab (BEV) and risk of arterial (ATE) and venous thromboembolism (VTE) in metastatic castration-resistant prostate cancer (mCRPC) patients treated on CALGB 90401(ALLIANCE) Cancer Research. 74: 3841-3841. DOI: 10.1158/1538-7445.Am2014-3841 |
0.352 |
|
| 2013 |
Garman KS, Owzar K, Hauser ER, Westfall K, Anderson BR, Souza RF, Diehl AM, Provenzale D, Shaheen NJ. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer. Digestive Diseases and Sciences. 58: 3178-88. PMID 23925817 DOI: 10.1007/S10620-013-2806-7 |
0.341 |
|
| 2013 |
DeMatteo RP, Ballman KV, Antonescu CR, Corless C, Kolesnikova V, von Mehren M, McCarter MD, Norton J, Maki RG, Pisters PW, Demetri GD, Brennan MF, Owzar K. Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial. Annals of Surgery. 258: 422-9. PMID 23860199 DOI: 10.1097/Sla.0B013E3182A15Eb7 |
0.343 |
|
| 2013 |
Patel JN, Fuchs CS, Owzar K, Chen Z, McLeod HL. Gastric cancer pharmacogenetics: progress or old tripe? Pharmacogenomics. 14: 1053-64. PMID 23837480 DOI: 10.2217/Pgs.13.88 |
0.366 |
|
| 2013 |
Lewis LD, Miller AA, Owzar K, Bies RR, Markova S, Jiang C, Kroetz DL, Egorin MJ, McLeod HL, Ratain MJ. The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance). Pharmacogenetics and Genomics. 23: 29-33. PMID 23188068 DOI: 10.1097/Fpc.0B013E32835B16D8 |
0.361 |
|
| 2013 |
McCarthy PL, Owzar K, Hahn T. Autologous hematopoietic stem cell transplantation and maintenance therapy for multiple myeloma International Journal of Hematologic Oncology. 2: 71-83. DOI: 10.2217/Ijh.13.2 |
0.307 |
|
| 2013 |
Dressler LG, Deal AM, Watson D, Hollis D, Owzar K, Donohue K, Friedman PN, Ratain MJ, McLeod HL. Participation in cancer pharmacogenomic studies in 8,456 patients registered to Cancer and Leukemia Group B (Alliance) clinical trials. Journal of Clinical Oncology. 31: 6501-6501. DOI: 10.1200/Jco.2013.31.15_Suppl.6501 |
0.33 |
|
| 2013 |
Siamakpour-Reihani S, Owzar K, Jiang C, Turner T, Berchuck A, Marks J, Dewhirst M, Secord AA. Prognostic significance of differential expression of angiogenic genes in women with invasive high-grade serous ovarian carcinoma. Journal of Clinical Oncology. 31: 5509-5509. DOI: 10.1200/Jco.2013.31.15_Suppl.5509 |
0.359 |
|
| 2013 |
Hertz DL, Owzar K, Halabi S, Kelly WK, Zembutsu H, Jiang C, Patel JN, Watson D, Shterev I, Kroetz DL, Friedman PN, Mahoney JF, Carducci MA, Kelley MJ, Small EJ, et al. A genome-wide association study (GWAS) of docetaxel-induced peripheral neuropathy in CALGB 90401 (Alliance). Journal of Clinical Oncology. 31: 11053-11053. DOI: 10.1200/Jco.2013.31.15_Suppl.11053 |
0.418 |
|
| 2013 |
Hurwitz H, Cushman S, Jiang C, Shterev I, Mahoney MR, Niedzwiecki D, Mayer RJ, Venook AP, Owzar K, Nixon AB. Tumor markers of efficacy and resistance to cetuximab (C) treatment in metastatic colorectal cancer (mCRC): Results from CALGB 80203 (Alliance). Journal of Clinical Oncology. 31: 11011-11011. DOI: 10.1200/Jco.2013.31.15_Suppl.11011 |
0.326 |
|
| 2013 |
Reihani SS, Jiang C, Turner T, Owzar K, Berchuck A, Dewhirst M, Secord AA. Abstract 330A: Differential expression of angiogenic genes in invasive high grade serous ovarian carcinomas. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-330A |
0.361 |
|
| 2012 |
Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, et al. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5099-109. PMID 22843789 DOI: 10.1158/1078-0432.Ccr-12-1590 |
0.364 |
|
| 2012 |
Owzar K, Li Z, Cox N, Jung SH. Power and sample size calculations for SNP association studies with censored time-to-event outcomes. Genetic Epidemiology. 36: 538-48. PMID 22685040 DOI: 10.1002/Gepi.21645 |
0.322 |
|
| 2012 |
Innocenti F, Owzar K, Cox NL, Evans P, Kubo M, Zembutsu H, Jiang C, Hollis D, Mushiroda T, Li L, Friedman P, Wang L, Glubb D, Hurwitz H, Giacomini KM, et al. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 577-84. PMID 22142827 DOI: 10.1158/1078-0432.Ccr-11-1387 |
0.404 |
|
| 2012 |
Roberts AS, Campa MJ, Gottlin EB, Jiang C, Owzar K, Kindler HL, Venook AP, Goldberg RM, O'Reilly EM, Patz EF. Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303). Cancer. 118: 571-8. PMID 21713765 DOI: 10.1002/Cncr.26270 |
0.379 |
|
| 2012 |
Beumer JH, Lewis LD, Owzar K, Jiang C, Holleran JL, Christner SM, Blum WG, Devine SM, Kolitz JE, Linker CA, Larson RA, Ratain MJ, Egorin MJ. Effect of age on the pharmacokinetics of busulfan (Bu): An alliance study. Journal of Clinical Oncology. 30: 2533-2533. DOI: 10.1200/Jco.2012.30.15_Suppl.2533 |
0.313 |
|
| 2012 |
Wetzler M, Watson D, Stock W, Owzar K, Koval G, Hoke E, McCarty JM, Blum W, Powell BL, Marcucci G, Bloomfield CD, Linker C, Larson RA. Autologous Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Achieves Outcomes Similar to Allogeneic Transplantation - Results of CALGB 10001 (Alliance) Blood. 120: 816-816. DOI: 10.1182/Blood.V120.21.816.816 |
0.354 |
|
| 2012 |
Devine SM, Owzar K, Blum W, DeAngelo D, Stone RM, Hsu JW, Champlin RE, Chen YA, Vij R, Slack JL, Soiffer RJ, Larson RA, Shea TC, Hars V, Bennett E, et al. A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502 Blood. 120: 230-230. DOI: 10.1182/Blood.V120.21.230.230 |
0.338 |
|
| 2012 |
Wheeler HE, Gamazon ER, Njiaju UO, Wing C, Njoku C, Baldwin RM, Owzar K, Winer E, Hudis C, Shulman LN, Ratain MJ, Kroetz DL, Cox NJ, Dolan ME. Abstract 1881: Integration of cell line and Cancer and Leukemia Group B 40101 clinical trial genome-wide association analyses implicates multiple loci in paclitaxel-induced peripheral neuropathy Cancer Research. 72: 1881-1881. DOI: 10.1158/1538-7445.Am2012-1881 |
0.413 |
|
| 2012 |
Innocenti F, Owzar K, Jiang C, Crona D, Etheridge A, Jassem J, Rzyman W, Hirsch F, Dziadziuszko R, Glubb D. 484 Germline Variants in Angiogenesis Genes as Markers of Progression-free Survival in Stage I-III Non-small Cell Lung Cancer Patients European Journal of Cancer. 48: 150. DOI: 10.1016/S0959-8049(12)72282-7 |
0.382 |
|
| 2011 |
Glubb DM, Zhang W, Owzar K, Jiang C, Mirza O, Kashyap S, Rzyman W, Jassem J, Hirsch FR, Dziadziuszko R, Innocenti F. Molecular studies support the association between germ-line genetic variants in the vascular endothelial growth factor (VEGF) pathway and survival in non-small cell lung cancer (NSCLC) patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7059. PMID 28020039 DOI: 10.1200/Jco.2011.29.15_Suppl.7059 |
0.362 |
|
| 2011 |
Owzar K, Barry WT, Jung SH. Statistical considerations for analysis of microarray experiments. Clinical and Translational Science. 4: 466-77. PMID 22212230 DOI: 10.1111/J.1752-8062.2011.00309.X |
0.334 |
|
| 2011 |
Lewis DA, Stashenko GJ, Akay OM, Price LI, Owzar K, Ginsburg GS, Chi JT, Ortel TL. Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism. Thrombosis Research. 128: 536-40. PMID 21737128 DOI: 10.1016/J.Thromres.2011.06.003 |
0.314 |
|
| 2011 |
Shea T, Johnson J, Westervelt P, Farag S, McCarty J, Bashey A, Isola L, Baxter-Lowe LA, Kelly M, Owzar K, Linker C. Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1395-403. PMID 21296675 DOI: 10.1016/J.Bbmt.2011.01.016 |
0.364 |
|
| 2011 |
Bashey A, Owzar K, Johnson JL, Edwards PS, Kelly M, Baxter-Lowe LA, Devine S, Farag S, Hurd D, Ball E, McCarthy P, Lister J, Shea TC, Linker C. Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 558-65. PMID 20674758 DOI: 10.1016/J.Bbmt.2010.07.015 |
0.332 |
|
| 2011 |
Ali-Osman F, Owzar K, Lipp E, Adams B, Illyasova D, McClendon R, Reardon D, Friedman A, Friedman H, Bigner D. Abstract PL07-01: Linkage disequilibrium-based analysis of DNA repair and GST genes in malignant gliomas: A unique tool in defining the association between genetic diversity and survival Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-Pl07-01 |
0.371 |
|
| 2011 |
Hamilton E, Hobeika A, Lyerly H, Owzar K, Rocha G, Kimmick G, Marcom P, Peppercorn J, Morse M, Blackwell K. P1-13-03: Zoledronic Acid Induces an Immune Response in Breast Cancer Patients through Stimulation of Central Memory and Effector Memory gamma/delta T-Cells. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-13-03 |
0.329 |
|
| 2010 |
McCarthy PL, Owzar K, Anderson KC, Hofmeister CC, Hassoun H, Hurd DD, Stadtmauer EA, Giralt S, Hars V, Linker CA, Calgb Ef, Bmt-Ctn. Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104. Journal of Clinical Oncology. 28: 8017-8017. DOI: 10.1200/Jco.2010.28.15_Suppl.8017 |
0.324 |
|
| 2010 |
Kroetz DL, Baldwin RM, Owzar K, Jiang C, Zembutsu H, Kubo M, Nakamura Y, Shulman LN, Ratain MJ. Inherited genetic variation in EPHA5, FGD4, and NRDG1 and paclitaxel (P)-induced peripheral neuropathy (PN): Results from a genome-wide association study (GWAS) in CALGB 40101. Journal of Clinical Oncology. 28: 3021-3021. DOI: 10.1200/Jco.2010.28.15_Suppl.3021 |
0.313 |
|
| 2010 |
McCarthy PL, Owzar K, Anderson KC, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Richardson PG, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile T, et al. Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104 Blood. 116: 37-37. DOI: 10.1182/Blood.V116.21.37.37 |
0.341 |
|
| 2009 |
Innocenti F, Owzar K, Cox N, Evans P, Kubo M, Hollis D, Mushiroda T, Kindler HL, Nakamura Y, Ratain MJ. Heritable interleukin-17F (IL17F) gene variation and overall survival (OS) in pancreatic cancer patients (pts): Results from a genome-wide association study (GWAS) in CALGB 80303. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4531. PMID 27962995 DOI: 10.1200/Jco.2009.27.15_Suppl.4531 |
0.405 |
|
| 2009 |
Halabi S, Vogelzang NJ, Ou SS, Owzar K, Archer L, Small EJ. Progression-free survival as a predictor of overall survival in men with castrate-resistant prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2766-71. PMID 19380448 DOI: 10.1200/Jco.2008.18.9159 |
0.343 |
|
| 2009 |
Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 373: 1097-104. PMID 19303137 DOI: 10.1016/S0140-6736(09)60500-6 |
0.347 |
|
| 2009 |
Linker CA, Owzar K, Powell B, Hurd D, Damon LE, Archer LE, Larson RA. Auto-SCT for AML in second remission: CALGB Study 9620 Bone Marrow Transplantation. 44: 353-359. PMID 19289999 DOI: 10.1038/Bmt.2009.36 |
0.341 |
|
| 2009 |
McCarthy PL, Owzar K, Stadtmauer EA, Giralt S, Hurd DD, Hassoun H, Hofmeister C, Richardson P, Weisdorf DJ, Pasquini MC, Hars V, Kelly M, Postiglione J, Sutherland S, Anderson KC, et al. Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events. Blood. 114: 3416-3416. DOI: 10.1182/Blood.V114.22.3416.3416 |
0.362 |
|
| 2009 |
Farag S, Owzar K, Hars V, Lazarus HM, Stadtmauer EA, Devine SM, Besien Kv, Linker C. A Prospective Multicenter Phase II Trial of Pentostatin in Adult Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease (cGvHD): A Cancer and Leukemia Group B/Eastern Cooperative Oncology Group Study. Blood. 114: 2238-2238. DOI: 10.1182/Blood.V114.22.2238.2238 |
0.357 |
|
| 2008 |
McLeod HL, Owzar K, Kroetz D, Innocenti F, Das S, Friedman P, Giacomini K, Goldberg RM, Venook AP, Ratain MJ. Cellular transporter pharmacogenetics in metastatic colorectal cancer: Initial analysis of C80203. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3513. PMID 27949752 DOI: 10.1200/Jco.2008.26.15_Suppl.3513 |
0.365 |
|
| 2008 |
Heinrich MC, Owzar K, Corless CL, Hollis D, Borden EC, Fletcher CD, Ryan CW, von Mehren M, Blanke CD, Rankin C, Benjamin RS, Bramwell VH, Demetri GD, Bertagnolli MM, Fletcher JA. Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5360-7. PMID 18955451 DOI: 10.1200/Jco.2008.17.4284 |
0.341 |
|
| 2008 |
Owzar K, Barry WT, Jung SH, Sohn I, George SL. Statistical challenges in preprocessing in microarray experiments in cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5959-66. PMID 18829474 DOI: 10.1158/1078-0432.Ccr-07-4532 |
0.344 |
|
| 2008 |
Owzar K, Jung SH. Designing phase II studies in cancer with time-to-event endpoints. Clinical Trials (London, England). 5: 209-21. PMID 18559409 DOI: 10.1177/1740774508091748 |
0.319 |
|
| 2008 |
Owzar K. Alternate statistical tools and limitations in genetic marker association studies in single-arm drug cancer trials. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1400-1. PMID 18349389 DOI: 10.1200/Jco.2007.14.7306 |
0.338 |
|
| 2007 |
Owzar K, Jung SH, Sen PK. A copula approach for detecting prognostic genes associated with survival outcome in microarray studies. Biometrics. 63: 1089-98. PMID 17484778 DOI: 10.1111/J.1541-0420.2007.00802.X |
0.506 |
|
| 2007 |
Glabbeke MMV, Owzar K, Rankin C, Simes J, Crowley J. Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors (GIST): A meta-analyis based on 1,640 patients (pts) Journal of Clinical Oncology. 25: 10004-10004. DOI: 10.1200/Jco.2007.25.18_Suppl.10004 |
0.303 |
|
| 2007 |
Shea TC, Johnston J, Walsh W, Farag S, McCarty J, Bashey A, Isola L, Stewart M, Kelly M, Owzar K, Linker C. Reduced Intensity Allogeneic Transplantation Provides High Disease-Free and Overall Survival in Patients (Pts) with Advanced Indolent NHL and CLL: CALGB 109901. Blood. 110: 486-486. DOI: 10.1182/Blood.V110.11.486.486 |
0.359 |
|
| 2007 |
Wetzler M, Stock W, Donohue KA, Owzar K, Sher DA, Hoke EE, McCarty JM, Blum WG, Powell BL, Bloomfield CD, Linker CA, Larson RA. Autologous Stem Cell Transplantation (SCT) Following Sequential Chemotherapy and Imatinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) — CALGB Study 10001. Blood. 110: 2869-2869. DOI: 10.1182/Blood.V110.11.2869.2869 |
0.348 |
|
| 2006 |
Wetzler M, Stock W, Owzar K, Sher DA, Hoke EE, Linker CA, Bloomfield CD, Larson RA. Sequential imatinib and chemotherapy yield reverse-transcriptase polymerase chain reaction (RT-PCR)-negative peripheral stem cell collections in Philadelphia (Ph) chromosome positive acute lymphoblastic leukemia (ALL)—Preliminary results of CALGB 10001 Journal of Clinical Oncology. 24: 6549-6549. DOI: 10.1200/Jco.2006.24.18_Suppl.6549 |
0.32 |
|
| 2006 |
Bashey A, Owzar K, Johnson JL, Devine SM, Shadduck RK, Shea TC, Linker C. Reduced-Intensity Allogeneic Transplantation after Failure of Autologous Transplantation: A Prospective Multi-Center CALGB Study. Blood. 108: 3122-3122. DOI: 10.1182/Blood.V108.11.3122.3122 |
0.332 |
|
| 2005 |
Jung SH, Owzar K, George SL. A multiple testing procedure to associate gene expression levels with survival. Statistics in Medicine. 24: 3077-88. PMID 16189805 DOI: 10.1002/Sim.2179 |
0.369 |
|
| Show low-probability matches. |